The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brubaker, J. O.
Right arrow Articles by Finberg, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brubaker, J. O.
Right arrow Articles by Finberg, R. W.

The Journal of Immunology, Vol 157, Issue 4 1598-1604, Copyright © 1996 by American Association of Immunologists

ARTICLES

Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus

JO Brubaker, CM Thompson, LA Morrison, DM Knipe, GR Siber and RW Finberg
Laboratory of Infectious Diseases, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

The immunogenic properties of a replication-defective herpes simplex virus HD-2, containing the Escherichia coli lacZ gene under control of the HSV ICP8 early gene promoter were studied in BALB/c mice. Experiments were designed to determine if the HD-2 virus preferentially stimulated either Th1- or Th2-associated immune responses to beta- galactosidase (beta gal). Sera from mice immunized i.p. or s.c. with virus HD-2, beta gal on aluminum phosphate adjuvant, or a control ICP8 deletion mutant, d301, were assayed for total and Ag-specific IgG1 and IgG2a Abs, beta gal-driven lymphocyte proliferation, and in vitro production of the cytokines IFN-gamma, IL-4, and IL-2. Viruses HD-2 and d301 preferentially stimulated the production of total serum IgG2a following two immunizations i.p. or a single immunization s.c., while only HD-2 virus stimulated in vivo production of beta gal-specific IgG2a serum Abs. In contrast, beta gal adsorbed on AIPO4 preferentially stimulated production of Ag-specific IgG1 serum Abs. The HD-2 virus also induced a potent cellular proliferative response to beta gal, which was still pronounced 5 wk after primary immunization. Cultured lymphocytes from HD-2-immunized mice produced IFN-gamma after 5 days in culture with soluble beta gal in an Ag- and dose-dependent fashion. These results demonstrate that replication-defective mutants of HSV can be used as vectors for eliciting Th1-associated immune responses to a heterologous Ag expressed from the viral genome.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
M. Gadjeva, A. Verschoor, M. A. Brockman, H. Jezak, L. M. Shen, D. M. Knipe, and M. C. Carroll
Macrophage-Derived Complement Component C4 Can Restore Humoral Immunity in C4-Deficient Mice
J. Immunol., November 15, 2002; 169(10): 5489 - 5495.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
T. L. Keadle, K. A. Laycock, J. L. Morris, D. A. Leib, L. A. Morrison, J. S. Pepose, and P. M. Stuart
Therapeutic vaccination with vhs- herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice
J. Gen. Virol., October 1, 2002; 83(10): 2361 - 2365.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. A. Brockman and D. M. Knipe
Herpes Simplex Virus Vectors Elicit Durable Immune Responses in the Presence of Preexisting Host Immunity
J. Virol., March 19, 2002; 76(8): 3678 - 3687.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Verschoor, M. A. Brockman, D. M. Knipe, and M. C. Carroll
Cutting Edge: Myeloid Complement C3 Enhances the Humoral Response To Peripheral Viral Infection
J. Immunol., September 1, 2001; 167(5): 2446 - 2451.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
B. J. Geiss, T. J. Smith, D. A. Leib, and L. A. Morrison
Disruption of Virion Host Shutoff Activity Improves the Immunogenicity and Protective Capacity of a Replication-Incompetent Herpes Simplex Virus Type 1 Vaccine Strain
J. Virol., December 1, 2000; 74(23): 11137 - 11144.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
X. Da Costa, M. F. Kramer, J. Zhu, M. A. Brockman, and D. M. Knipe
Construction, Phenotypic Analysis, and Immunogenicity of a UL5/UL29 Double Deletion Mutant of Herpes Simplex Virus 2
J. Virol., September 1, 2000; 74(17): 7963 - 7971.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
P. J. Lewis, S. van Drunen Littel-van den Hurk, and L. A. Babiuk
Altering the Cellular Location of an Antigen Expressed by a DNA-Based Vaccine Modulates the Immune Response
J. Virol., December 1, 1999; 73(12): 10214 - 10223.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
X. J. Da Costa, M. A. Brockman, E. Alicot, M. Ma, M. B. Fischer, X. Zhou, D. M. Knipe, and M. C. Carroll
Humoral response to herpes simplex virus is complement-dependent
PNAS, October 26, 1999; 96(22): 12708 - 12712.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A.-G. Ziady, T. Ferkol, D. V. Dawson, D. H. Perlmutter, and P. B. Davis
Chain Length of the Polylysine in Receptor-targeted Gene Transfer Complexes Affects Duration of Reporter Gene Expression Both in Vitro and in Vivo
J. Biol. Chem., February 19, 1999; 274(8): 4908 - 4916.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. K. Halak, H. C. Maguire Jr., and E. C. Lattime
Tumor-induced Interleukin-10 Inhibits Type 1 Immune Responses Directed at a Tumor Antigen As Well As a Non-Tumor Antigen Present at the Tumor Site
Cancer Res., February 1, 1999; 59(4): 911 - 917.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.